期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Formulation and Evaluation of Mucoadhesive Microspheres of Pioglitazone Hydrochloride Prepared by Ionotropic External Gelation Technique
1
作者 Nagarajan Sriram Prakash Katakam 《Journal of Encapsulation and Adsorption Sciences》 2016年第1期22-34,共13页
Microspheres containing Pioglitazone hydrochloride were prepared by the ionotropic external gelation method, using sodium alginate with four mucoadhesive polymers namely sodium carboxy methyl cellulose, hydroxy propyl... Microspheres containing Pioglitazone hydrochloride were prepared by the ionotropic external gelation method, using sodium alginate with four mucoadhesive polymers namely sodium carboxy methyl cellulose, hydroxy propyl methyl cellulose, carbopol 934 P and cellulose acetate phthalate as coat materials. Ionotropic gelation is a method to prepare microspheres using combination of Ca<sup>2+</sup> as cationic components and alginate as anion. The practical yield of prepared microspheres using the ionotropic gelation technique was between 172 mg and 604 mg. The result of the Chi-squared test carried out between the actual (practical) and expected (theoretical) yields showed no significant difference (P < 0.05) which indicated that the ionotropic gelation technique could be successfully employed to prepare pioglitazone microspheres using sodium alginate, sodium carboxy methyl cellulose, carbopol 934 P, HPMC, cellulose acetate butyrate polymers. The drug entrapment efficiency of prepared microspheres showed between 56.12% ± 3.86% to 84.68% ± 2.93% which was significantly higher for ionotropic gelation technique. The highest drug entrapment was found in formulation PMI 8. Swelling index is the capability of a polymer to swell before the drug is released which influences the rate and mechanism of drug release from the polymer matrix. The swelling index of prepared microspheres was in the range of 68% ± 4.52% to 87% ± 0.98%. Pioglitazone HCl microspheres showed controlled release of drug without initial peak level achieving. This type of properties in Pioglitazone HCl microspheres used to decrease side effects, reduce dosing frequency and improve patient compliances. From the all batches PMI 8 is considered the best formulation, because among all other formulations, it shows better extent of drug release up to 82.12% (18 h), good entrapment efficiency (84.68%) and the ex-vivo wash-off test shows the best mucoadhesive property. The in vitro drug release studies do up to 18 h. As observed from the various plots, most of th 展开更多
关键词 Diabetes Mellitus mucoadhesive microspheres mucoadhesive Polymers mucoadhesION Sustained Release Ionotropic External Gelation Technique
下载PDF
重组人白介素-2壳聚糖鼻腔黏附微球的制备、评价及对家兔过敏性鼻炎的药效研究 被引量:3
2
作者 汤玥 任海霞 +2 位作者 姜力群 程度胜 朱家壁 《中国药学杂志》 CAS CSCD 北大核心 2010年第17期1335-1339,共5页
目的制备重组人白介素-2(rhIL-2)壳聚糖鼻腔黏附微球。并评价其用于过敏性鼻炎的可能性。方法采用沉淀方法制备载药微球,并对其外观形态、粒径、Zeta电位、载药量以及体外释放行为进行考察。结果以相对分子质量较大的壳聚糖制备的微球... 目的制备重组人白介素-2(rhIL-2)壳聚糖鼻腔黏附微球。并评价其用于过敏性鼻炎的可能性。方法采用沉淀方法制备载药微球,并对其外观形态、粒径、Zeta电位、载药量以及体外释放行为进行考察。结果以相对分子质量较大的壳聚糖制备的微球具有较大的粒径。体外释放实验表明,rhIL-2壳聚糖微球具有一定的缓释效果。黏膜纤毛迁移速率实验显示壳聚糖微球具有黏膜黏附性。家兔过敏性鼻炎实验表明,鼻腔给予该制剂可以缓解过敏性鼻炎症状,减少打喷嚏的发生率并且降低血浆中NO的含量。结论 rhIL-2壳聚糖微球比相同剂量rhIL-2溶液具有更好的效果。 展开更多
关键词 重组人白介素-2 鼻腔黏附性微球 壳聚糖 过敏性鼻炎
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部